This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe

Savings Deadline Expires In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2-4 December 2024
Convention Centre DublinDublin, Ireland

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Profile

For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small and mid-sized pharmaceutical and biotech companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through ground-breaking therapies and medical technology.

EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE takes pride in providing expert insights into EU policies and legislation as well as market access, aiding our members in navigating the complex world of health technologies in Europe. EUCOPE’s network and trusted relationships with established stakeholders at the EU and national levels help our members connect and share experiences with the European Commission, the European Parliament, Member States’ representatives, patient organisations, healthcare professionals and payers, academics, and other industry associations.

We provide our small and mid-sized biopharmaceutical members a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures at the EU and Member State level.

Our commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall.